Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Nanomedicine system engineered to enhance therapeutic effects of injectable drugs

Mauro Ferrari, PhD.

Credit: (The University of Texas Health Science Center at Houston)
Mauro Ferrari, PhD.
Credit: (The University of Texas Health Science Center at Houston)

Abstract:
In an article featured on the cover of the March issue of "Nature Nanotechnology," Mauro Ferrari, Ph.D., of The University of Texas Health Science Center at Houston presented a proof-of-concept study on a new multistage delivery system (MDS) for imaging and therapeutic applications. This discovery could go a long way toward making injectable drugs more effective. The study is included in the March 2 Advance Online Publication on "Nature Nanotechnology's" Web site (www.nature.com/nnano/index.html)

Nanomedicine system engineered to enhance therapeutic effects of injectable drugs

Houston, TX | Posted on March 3rd, 2008

"This is next generation nanomedicine," said Ferrari, the senior author. "Now, we're engineering sophisticated nanostructures to elude the body's natural defenses, locate tumors and other diseased cells, and release a payload of therapeutics, contrasting agents, or both over a controlled period. It's the difference between riding a bicycle and a motorcycle."

The study - "Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications" - was conducted with researchers from The University of Texas M. D. Anderson Cancer Center and Rice University.

Nanotechnology offers new and powerful tools to design and to engineer novel drug delivery systems and to predict how they will work once inside the body. "The field of therapeutic nanoparticles began with tiny drug-encapsulated fat bubbles called liposomes, now commonly used in cancer clinics worldwide. Targeting molecules were later added to liposomes and other nanovectors to assist in directing them to diseased cells," Ferrari said.

Getting intravenous agents to their intended targets is no easy task. It's estimated that approximately one of every 100,000 molecules of agent reaches its desired destination. Physicians are faced with the quandary of increasing the dosage, which can lead to side effects or reducing the dosage, which can limit the therapeutic benefits.

The multistage approach, according to Ferrari, is needed to circumvent the body's natural defenses or biobarriers, which act as obstacles to foreign objects injected in the blood stream. "To overcome this problem, we hypothesized and developed a multifunctional MDS comprising stage 1 mesoporous particles loaded with one or more types of stage 2 nanoparticles, which can in turn carry either active agents or higher-stage particles. We have demonstrated the loading, controlled release and simultaneous in vitro delivery of quantum-dots and carbon nanotubes to human vascular cells," the authors write.

In addition to circumventing biobarriers, Ferrari's team is working on the biochemical modifications required to efficiently deliver the MDS to a specific cancer lesion. "We have preliminary data that show that we can localize a payload of diagnostic agents, therapeutic agents or combination of both to target cells. Once on site, the molecules can be released in a controlled way and then the MDS will degrade in 24 to 48 hours, be transformed into orthosilicic acid and leave no trace in the body," Ferrari said.

Lead author Ennio Tasciotti, Ph.D., senior postdoctoral fellow in the NanoMedicine Research Center at the UT Health Science Center at Houston, said the proof-of-concept study would have not been possible without a multidisciplinary effort including contributions from mathematicians, physicists, engineers, chemists and biologists.

"We are dealing with objects that are in the billionth of a meter size range and to study such objects we used cutting edge technologies," Tasciotti said. "The characterization of the particles was performed using scanning electron and atomic force microscopy, dynamic light scattering, fluorimetry and flow cytometry. The interaction of particles with cells was studied using fluorescence and confocal microscopy as well as a series of assays intended to determine cell viability and internalization rate of the nanoparticles."

Ferrari heads the 40-person NanoMedicine Research Center in the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), a part of the UT Health Science Center at Houston, as well as the Alliance for NanoHealth, a consortium made up of UT Houston and six other institutions. Ferrari serves as chair of the Department of Biomedical Engineering at the UT Health Science Center at Houston, professor of Experimental Therapeutics at the UT M. D. Anderson Cancer Center, professor of bioengineering at Rice University and professor of biochemistry and molecular biology at The University of Texas Medical Branch at Galveston.

Collaborators include Ashley Leonard, Katherine Price and James Tour, Ph.D., all with Rice University, and Fredika Robertson, Ph.D., of UT M. D. Anderson Cancer Center.

Ferrari's coauthors from the NanoMedicine Research Center include: Xuewu Liu, Ph.D., Rohan Bhavane, Ph.D., Ming-Cheng "Mark" Cheng, Ph.D., Kevin Plant and Paolo Decuzzi, Ph.D.

####

For more information, please click here

Contacts:
Robert Cahill

713-500-3030

Copyright © University of Texas Health Science Center at Houston

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nanoscale worms provide new route to nano-necklace structures March 29th, 2015

Solving molybdenum disulfide's 'thin' problem: Research team increases material's light emission by twelve times March 29th, 2015

A first glimpse inside a macroscopic quantum state March 28th, 2015

DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015

Imaging

FEI Technology Award of the German Neuroscience Society Goes to Benjamin Judkewitz of the University of Berlin: Bi-annual award honors excellence in brain research during the German Neuroscience Society’s Annual Meeting, held 18-21 March 2015 March 26th, 2015

Square ice filling for a graphene sandwich March 26th, 2015

Renishaw reports on the use of Raman spectroscopy at CNRS Orléans to study materials under extreme conditions March 25th, 2015

Nanorobotic agents open the blood-brain barrier, offering hope for new brain treatments March 25th, 2015

Nanomedicine

Novel nanoparticle therapy promotes wound healing March 27th, 2015

Graphene reduces wear of alumina ceramic March 26th, 2015

Application of Graphene Oxide in Body Implants in Iran March 26th, 2015

Nanorobotic agents open the blood-brain barrier, offering hope for new brain treatments March 25th, 2015

Discoveries

Nanoscale worms provide new route to nano-necklace structures March 29th, 2015

Solving molybdenum disulfide's 'thin' problem: Research team increases material's light emission by twelve times March 29th, 2015

A first glimpse inside a macroscopic quantum state March 28th, 2015

Designer's toolkit for dynamic DNA nanomachines: Arm-waving nanorobot signals new flexibility in DNA origami March 27th, 2015

Announcements

Nanoscale worms provide new route to nano-necklace structures March 29th, 2015

Solving molybdenum disulfide's 'thin' problem: Research team increases material's light emission by twelve times March 29th, 2015

A first glimpse inside a macroscopic quantum state March 28th, 2015

DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE